CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE

USPTO Patent Application US 2017/0042837 A1
Application Date: Feb. 16th, 2017

ABSTRACT

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed ToprolXL® tablet....
Application Number:
15/337,611
International Classification:
A61K 31/138 (20060101); A61K 9/00 (20060101); A61K 9/48 (20060101)
No Pictures Available

CLAIMS

We claim:

1. An extended-release capsule dosage form of metoprolol succinate comprising coated discrete units having a d90 value between about 0.2 mm and 1.5 mm, wherein the coated discrete units, after dispersing in an aqueous media for at least 10 minutes, have a desired flowability when passed through a feeding tube...

DESCRIPTION

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. application Ser. No. 15/012,775 filed Feb. 1, 2016, which is a continuation of PCT Application No. PCT/IB2015/055195 filed Jul. 9, 2015, which claims the benefit of U.S. Provisional Application No. 62/022,316 filed Jul. 9, 2014.
Back to Top